Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research · 2 days ago
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29Business Wire · 5 days ago
Contrasting Establishment Labs (NASDAQ:ESTA) & OraSure Technologies (NASDAQ:OSUR)Defense World · Oct 7, 2026
Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®Business Wire · Oct 5, 2026
Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic ImplantsBusiness Wire · Sep 21, 2026
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from BrokeragesDefense World · Sep 21, 2026Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.34 | -$0.39 | Miss |
| May 6, 2026 | -$0.35 | -$0.40 | Miss |
| Feb 24, 2026 | -$0.22 | -$0.09 | Beat |
| Nov 5, 2025 | -$0.54 | -$0.38 | Beat |
| Aug 7, 2025 | -$0.54 | -$0.57 | Miss |
| May 7, 2025 | -$0.83 | -$0.70 | Beat |